Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,285 | 33 | 99.3% |
| Travel and Lodging | $12.00 | 1 | 0.5% |
| Education | $5.12 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $793.99 | 6 | $0 (2018) |
| Boston Scientific Corporation | $447.18 | 8 | $0 (2023) |
| Abbott Laboratories | $216.54 | 3 | $0 (2023) |
| SPR Therapeutics, Inc | $134.55 | 1 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $122.99 | 3 | $0 (2017) |
| ABBVIE INC. | $114.61 | 3 | $0 (2024) |
| Medtronic USA, Inc. | $98.59 | 1 | $0 (2018) |
| Curonix LLC | $97.95 | 1 | $0 (2024) |
| Purdue Pharma L.P. | $89.13 | 1 | $0 (2017) |
| Nalu Medical, Inc. | $80.21 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $228.15 | 6 | Curonix LLC ($97.95) |
| 2023 | $233.07 | 4 | SPR Therapeutics, Inc ($134.55) |
| 2022 | $28.09 | 2 | ABBVIE INC. ($14.62) |
| 2020 | $16.64 | 1 | Boston Scientific Corporation ($16.64) |
| 2019 | $60.44 | 2 | Boston Scientific Corporation ($60.44) |
| 2018 | $1,472 | 15 | Merz North America, Inc. ($793.99) |
| 2017 | $263.50 | 6 | Collegium Pharmaceutical, Inc. ($122.99) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Pain Management | ||||||
| 04/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $97.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/26/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Pain Management | ||||||
| 01/23/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Pain Management | ||||||
| 01/18/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Pain Management | ||||||
| 11/08/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/28/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $134.55 | General |
| Category: Pain management | ||||||
| 10/27/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Neuromodulation | ||||||
| 08/05/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| 07/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2020 | Boston Scientific Corporation | GENERAL - PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/16/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/16/2019 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $46.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/13/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/28/2018 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $200.00 | General |
| 11/06/2018 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| 11/01/2018 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $250.00 | General |
| 11/01/2018 | Merz North America, Inc. | XEOMIN (Biological), ASCLERA | Food and Beverage | Cash or cash equivalent | $200.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2018 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Sleep | ||||||
| 10/02/2018 | Merz North America, Inc. | XEOMIN (Biological), ASCLERA | Food and Beverage | Cash or cash equivalent | $24.70 | General |
| Category: DERMATOLOGY | ||||||
| 09/07/2018 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $156.99 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/16/2018 | Medtronic USA, Inc. | ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $98.59 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/09/2018 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $41.95 | General |
| Category: Sleep | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 140 | 924 | $128,585 | $25,532 |
| 2022 | 17 | 346 | 842 | $173,564 | $45,263 |
| 2021 | 4 | 94 | 419 | $71,308 | $19,284 |
| 2020 | 7 | 129 | 473 | $60,052 | $14,657 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 147 | $58,800 | $14,035 | 23.9% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 15 | 458 | $45,800 | $7,894 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $11,500 | $2,632 | 22.9% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 13 | 37 | $3,145 | $718.94 | 22.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 168 | $5,880 | $139.79 | 2.4% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 11 | 11 | $660.00 | $102.84 | 15.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 20 | 80 | $2,800 | $9.77 | 0.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 180 | $72,000 | $17,554 | 24.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 26 | 54 | $11,448 | $5,459 | 47.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 12 | 12 | $9,015 | $3,795 | 42.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 26 | 30 | $10,214 | $3,145 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $12,000 | $2,920 | 24.3% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2022 | 12 | 12 | $5,992 | $2,572 | 42.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 11 | 14 | $7,700 | $2,254 | 29.3% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 24 | 28 | $10,935 | $2,060 | 18.8% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 13 | 16 | $5,600 | $1,552 | 27.7% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 12 | 12 | $3,071 | $1,267 | 41.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 38 | $7,600 | $718.01 | 9.4% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2022 | 12 | 12 | $1,594 | $648.37 | 40.7% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 28 | 46 | $2,760 | $425.59 | 15.4% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2022 | 12 | 12 | $912.38 | $347.91 | 38.1% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 12 | 12 | $912.38 | $341.15 | 37.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 34 | 216 | $7,520 | $191.79 | 2.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 25 | 124 | $4,290 | $11.30 | 0.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 157 | $50,236 | $15,103 | 30.1% |
About Dr. Robert Groysman, M.D
Dr. Robert Groysman, M.D is a Pain Medicine healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194728352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Groysman, M.D has received a total of $2,302 in payments from pharmaceutical and medical device companies, with $228.15 received in 2024. These payments were reported across 36 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,285).
As a Medicare-enrolled provider, Groysman has provided services to 709 Medicare beneficiaries, totaling 2,658 services with total Medicare billing of $104,736. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology, Interventional Pain Medicine
- Location Plano, TX
- Active Since 05/23/2005
- Last Updated 03/26/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1194728352
Products in Payments
- SPECTRA WAVEWRITER (Device) $391.37
- XEOMIN (Biological) $324.70
- Proclaim Family of SCS IPGs (Device) $156.99
- SPRINT PNS System (Device) $134.55
- Xtampza ER (Drug) $122.99
- QULIPTA (Drug) $114.61
- ADAPTIVESTIM (Device) $98.59
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $97.95
- Nalu Neurostimulation System (Device) $80.21
- Horizant (Drug) $57.07
- SCS IPGs (Device) $36.61
- WaveWriter Alpha Prime 16 (Device) $25.58
- OCTRODE (Device) $22.94
- Physio-Stim (Biological) $21.08
- GENERAL - PAIN MANAGEMENT (Device) $16.64
- Peripheral Orbital Atherectomy System (Device) $14.77
- GENERAL PAIN MANAGEMENT (Device) $13.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Plano
Noor Gajraj, Md, MD
Pain Medicine — Payments: $326,435
Tejas Ozarkar, Md, MD
Pain Medicine — Payments: $19,560
Dr. Sameer Syed, M.d, M.D
Pain Medicine — Payments: $18,021
Dr. Robert Nocerini, Md, MD
Pain Medicine — Payments: $7,013
Dr. Gonzalo Gonzales Jr., D.o, D.O
Pain Medicine — Payments: $5,253
Arfan Qureshi, D.o, D.O
Pain Medicine — Payments: $3,396